Ohio biotech CEO discusses headway on possible coronavirus treatment
Athersys聽CEO Gil Van Bokkelen told 'America's Newsroom' his company has been in聽active discussions with the FDA over the past few weeks about the design and implementation of a large-scale study focused specifically on COVID-19 patients
